Citation Impact
Citing Papers
The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance
2005
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Genetic coregulation of age of female sexual maturation and lifespan through circulating IGF1 among inbred mouse strains
2012
The Somatomedin Hypothesis: 2001
2001
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
Human conditions of insulin-like growth factor-I (IGF-I) deficiency
2012
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Acromegaly
2006 Standout
Type 2 Diabetes in Children: Clinical Aspects and Risk Factors
2002
Nutritional Regulation of the Insulin-Like Growth Factors*
1994
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
The β-Thalassemias
1999 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men
1990
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
2005 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Phaeochromocytoma
2005 Standout
In Situ Evidence That Peripheral Insulin Resistance in Adolescents with Poorly Controlled Type 1 Diabetes Is Associated with Impaired Suppression of Lipolysis: A Microdialysis Study
2003
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Serum Insulin and Other Cardiovascular Risk Indicators in Children, Adolescents and Young Adults
1991
Maternal and child undernutrition: consequences for adult health and human capital
2008 Standout
Acromegaly
1990
Effects of iron overload on chronic metabolic diseases
2014
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Insulin resistance and hyperinsulinemia in homozygous β-thalassemia
1995
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
1994
Acromegaly
1994
Diabetes in Asia
2009 Standout
A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study
2006
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Biology of Incretins: GLP-1 and GIP
2007 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Type 2 diabetes
2017 Standout
Acne vulgaris
2011 Standout
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Nonalcoholic Steatohepatitis in Children
2000
Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results
2003
Nutrition, hormones, and breast cancer: Is insulin the missing link?
1996
Predicting Obesity in Young Adulthood from Childhood and Parental Obesity
1997 Standout
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
2013 Standout
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
α-Thalassaemia trait and gestational diabetes mellitus in Hong Kong
2001
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
1998 StandoutNature
Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women
2004
Acromegalic cardiopathy improves after treatment with increasing doses of octreotide
1991
The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.
1996
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
Obesity in children and young people: a crisis in public health
2004 Standout
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Cellular and clinical perspectives on skeletal insulin‐like growth factor I
1994
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
2013 Standout
Frailty in elderly people
2013 Standout
A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial
2007
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner’s syndrome
1999
cAMP‐dependent protein phosphorylation of membrane proteins in the parotid gland, platelets and liver
1988
Anemia of Chronic Disease
2005 Standout
Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: A meta-analysis
2007
The Somatomedin Hypothesis: 2001
2001
Partial Deletion of Pten in the Hypothalamus Leads to Growth Defects that Cannot be Rescued by Exogenous Growth Hormone
2008 StandoutNobel
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Sex steroids and insulin resistance
2002
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism
1994
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats
1991
Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes
2005
Synapsin II. Mapping of a domain in the NH2-terminal region which binds to small synaptic vesicles.
1990 StandoutNobel
Nonalcoholic Steatohepatitis in Children
2000
β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?
2013
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
Visualization of a ganglioneuroma by means of scintigraphy with 131-I-MIBG
1986
Mechanisms of Diabetic Complications
2013 Standout
Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995
1985
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Iron-Deficiency Anemia
2015 Standout
One Year of Insulin-Like Growth Factor I Treatment Does Not Affect Bone Density, Body Composition, or Psychological Measures in Postmenopausal Women1
2001
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78‐week randomized, double‐blind, placebo‐controlled trial
2015
The Role of Iron in Diabetes and Its Complications
2007
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Increased protein synthesis after acute IGF-I or insulin infusion is localized to muscle in mice
1998
Cellular and Molecular Regulation of Muscle Regeneration
2004 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut
1989
Abnormal Glucose Tolerance in Transfusion-Dependent β-Thalassemic Patients
2001
Obesity and endocrine disease
2003
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2006
Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans
1991
A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia
2009
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes
2003
Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition
2000
Hypoglycemia in Type 2 Diabetes
2005
Works of G. Plewe being referenced
Insulin Resistance of Puberty: a Defect Restricted to Peripheral Glucose Metabolism*
1991
Combination of Oral Antidiabetic Agents with Basal Insulin Versus Premixed Insulin Alone in Randomized Elderly Patients with Type 2 Diabetes Mellitus
2007
Insulin Resistance and Hyperinsulinemia in Patients with Thalassemia Major Treated by Hypertransfusion
1988
Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.
1989
Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma
1988
Effect of growth hormone treatment on hyperinsulinemia associated with turner syndrome
1992
Increased insulin secretion in puberty: A compensatory response to reductions in insulin sensitivity
1989
Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans
1987
Somatostatin Analogue SMS 201-995 in Type I Diabetes Mellitus: Initial Experience after Repeated Administration
1986
LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALY
1984
Comparison of131I-metaiodobenzylguanidine scintigraphy with urinary and plasma catecholamine determinations in the diagnosis of pheochromocytoma
1985
Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995 over 6 months
1986
Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes
2005
Suppression of Growth Hormone and Somatomedin C by Long-Acting Somatostatin Analog SMS 201–995 in Type I Diabetes mellitus
1987
Specific phosphorylation of a protein in calcium accumulating endoplasmic reticulum from rat parotid glands following stimulation by agonists involving cAMP as second messenger
1984
Treatment of APUDomas with the Long-Acting Somatostatin Analogue SMS 201-995: Investigations of Therapeutic Use and Digestive Side Effects
1986